Search Press releases Keywords From To 22 Sep 2022 UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting Read More 20 Sep 2022 European Medicine Agency Accepts Marketing Authorization Applications for Bimekizumab in Psoriatic Arthritis and Axial Spondyloarthritis Read More 9 Sep 2022 Disposal of own shares Read More 9 Sep 2022 ASBMR 2022: 3D modelling of hip DXA scans in postmenopausal women with osteoporosis reveals superior improvements in bone density of romosozumab versus controls Read More 7 Sep 2022 New Three-Year BIMZELX[®]▼ (bimekizumab) Data Reinforce Long-Term Maintenance of Complete Skin Clearance in Moderate to Severe Plaque Psoriasis Read More 1 Sep 2022 UCB Showcases Strength of the Expanding Dermatology Portfolio at the 31st EADV Congress Read More Pagination First page Previous page Previous … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
